Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897767 · ClinicalTrials.gov registry record
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
A clinical trial, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- 1,873
- Enrollment target
NCT00897767: Completed study, sponsored by Eastern Cooperative Oncology Group.
NCT00897767 is a clinical trial that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 1,873 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897767 has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- 1,873 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and determine a patient's eligibility for a treatment clinical trial. It may also help the study of cancer in the future. PURPOSE: This laboratory study is collecting tissue samples from patients with leukemia or other blood disorders who are planning to enroll in an ECOG leukemia treatment clinical trial.
Interventions
- OTHER biologic sample preservation procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,873 participants |
| Start Date | 2004-09-21 |
| Est. Completion | 2014-12-21 |
What the finished NCT00897767 record still lists
NCT00897767 is an observational study that tracks outcomes without assigning an intervention. Its 1,873 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which biologic sample preservation procedure is the first listed.
NCT00897767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897767 about?
NCT00897767 is a clinical study titled "Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial". RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and determine a patient's eligibility for a treatment clinical trial. It may also help the study of cancer in the future. PURPO...
What is the current status of trial NCT00897767?
This trial is currently completed. The enrollment target is 1,873 participants. The study started on 2004-09-21. Estimated completion is 2014-12-21.
What interventions are being tested in trial NCT00897767?
The interventions under investigation include: biologic sample preservation procedure (OTHER).
Who is sponsoring clinical trial NCT00897767?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07203313 · 1,872 participants · NA
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
- NCT05675410 · 1,875 participants · Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- NCT06891898 · 1,875 participants
The iLet Experience Study
- NCT07356089 · 1,875 participants
Twiist Postmarket Surveillance Study for Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI